UBS Maintains Buy on SI-BONE, Raises Price Target to $25

Benzinga Newsdesk www.benzinga.com Positive 80.8%

Neg 0% Neu 0% Pos 80.8%

UBS analyst Patrick Wood maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $24 to $25.

Comments

No comments yet. Be the first!